 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
17th Nov – 29th Dec 2009
Full articles available on request from Vivisectionkills@hotmail.com
Pfizer cancer drug abandoned as it doesn’t work
Atherosclerosis drug fails
Concerns over diabetes drug Byetta
Safety concerns over insomnia drug
$8 million damages paid by Pfizer
Sanofi abandons two drugs citing ‘risk-benefit’ concerns
Antidepressants increase risk of stroke and death
Blood pressure drug fails
December FDA bulletin lists 44 products with new warnings
Paxil lawsuits total $1,000,000,000
Elan Alzheimer’s treatment abandoned
HIV gel trial abandoned
Reboxetine doesn’t work according to German regulators
Clot busters may be dangerous
FDA monitors MRI drugs
Prostate drug fails
Tamiflu fails to protect patients
FDA wants review of kids antipsychotics
Pfizer to pay $103,000,000 over breast cancer
Vioxx: the dangers were known earlier but sales continued
More patients died in Cubist Pharm drug trials
FDA reveal dangers of Novartis drug everolimus
Tamiflu can give kids fever
Diabetes drugs and heart failure
FDA issue warning on Voltaren Gel
Desipramine warnings increased
FDA asked to ban Meridia
FDA warn on Lexiva
FDA warn on Norpramin
FDA warn on Meridia
FDA rejects Ampligen
Pfizer pay $34,300,000 to patient
Drugmakers ordered to pay $34,000,000 and $78,000,000
Picoplatin fails clinical trial
New study questions statins
FDA warn on 26 medications.
Aranesp does little for patients
Elevated cholesteral problems for Merck drugs Vytorin and Zetia
'the best guess for the correlation of adverse reactions in man and animal toxicity data is somewhere between 5% and 25%' Animal Toxicity Studies: Their Relevance to Man, Lumley and Walker (eds) (Quay, 1989), 57-67
Related Articles:
